Catalyst Wire Dossier Catalyst Wire Dossier

99mTc-ECDG

Technetium-99m ECDG · Cell>Point LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 99mTc-ECDG, covering 2025-04-01 to 2025-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD) [Phase 2]

See pricing